Pros and cons of Roux en-Y gastric bypass surgery in obese patients with type 2 diabetes

References

• Who.int [internet]. Obesity and overweight. Genneva: World Health Organization; 2016 [Accessed 2019 Apr 11]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
   Google Scholar
• Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011;378(9785):31–40.
   PubMed Web of Science ®Google Scholar
• The look AHEAD research group, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–154.
   PubMed Web of Science ®Google Scholar
• The look AHEAD research group,  Gregg EW, Jakicic JM, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes : a post-hoc analysis of the look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4(11):913–921.
   PubMed Web of Science ®Google Scholar
• Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures : IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2279–2289.
   PubMed Web of Science ®Google Scholar
• Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Obes Surg. 2017;27(1):2–21.
   PubMed Web of Science ®Google Scholar
• Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–1576.
   PubMed Web of Science ®Google Scholar
• Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 3-year outcomes. N Engl J Med. 2014;370(21):2002–2013.
   PubMed Web of Science ®Google Scholar
• Ikramuddin S, Korner J, Lee W, et al. Lifestyle intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A, LDL cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study. Jama. 2018;319(3):266–278.
   PubMed Web of Science ®Google Scholar
• Parikh M, Chung M, Sheth S, et al. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do not meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg. 2014;260(4):617–624.
   PubMed Web of Science ®Google Scholar
• Horwitz D, Saunders JK, Ude-Welcome A, et al. Three-year follow-up comparing metabolic surgery versus medical weight management in patients with type 2 diabetes and BMI 30–35. The role of sRAGE biomarker as predictor of satisfactory outcomes. Surg Obes Relat Dis. 2016;12(7):1337–1342.
   PubMed Web of Science ®Google Scholar
• Courcoulas AP, Goodpaster BH, Eagleton JK, et al. Surgical vs medical treatments for type 2 diabetes mellitus: A randomized clinical trial. JAMA Surg. 2014;149(7):707–715.
   PubMed Web of Science ®Google Scholar
• Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment a randomized clinical trial. JAMA Surg. 2015;150(10):931–940.
   PubMed Web of Science ®Google Scholar
• Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016;59(5):945–953.
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu Q, Chen B, et al. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: A randomized controlled trial. Diabetes Res Clin Pract. 2013;101(1):50–56.
   PubMed Web of Science ®Google Scholar
• Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes. N Engl J Med. 2017;376(7):641–651.
   PubMed Web of Science ®Google Scholar
• Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–1585.
   PubMed Web of Science ®Google Scholar
• Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–973.
   PubMed Web of Science ®Google Scholar
• Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014;149(7):716–726.
   PubMed Web of Science ®Google Scholar
• Simonson DC, Halperin F, Foster K, et al. Clinical and patient-centered outcomes in obese patients with type 2 diabetes 3 years after randomization to Roux-en-Y gastric bypass surgery versus intensive lifestyle management: the SLIMM-T2D study. Diabetes Care. 2018;41(4):670–679.
   PubMed Web of Science ®Google Scholar
• Ikramuddin S, Korner J, Lee W, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. Jama. 2013;309(21):2240–2249.
   PubMed Web of Science ®Google Scholar
• Ikramuddin S, Billington CJ, Lee WJ, et al. Roux-en-Y gastric bypass for diabetes (the diabetes surgery study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol. 2015;3(6):413–422.
   PubMed Web of Science ®Google Scholar
• Ikramuddin S, Korner J, Lee WJ, et al. Durability of addition of Roux-en-Y gastric bypass to lifestyle intervention and medical management in achieving primary treatment goals for uncontrolled type 2 diabetes in mild to moderate obesity: A randomized control trial. Diabetes Care. 2016;39(9):1510–1518.
   PubMed Web of Science ®Google Scholar
• Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–234.
   PubMed Web of Science ®Google Scholar
• Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. Jama. 2014;311(22):2297–2304.
   PubMed Web of Science ®Google Scholar
• Adams TD, Davidson LE, Litwin SE, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377(12):1143–1155.
   PubMed Web of Science ®Google Scholar
• Courcoulas AP, King WC, Belle SH, et al. Seven-year weight trajectories and health outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) study. JAMA Surg. 2018;153(5):427–434.
   PubMed Web of Science ®Google Scholar
• Maciejewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016;151(11):1046–1055.
   PubMed Web of Science ®Google Scholar
• Arterburn D, Wellman R, Emiliano A, et al. Comparative effectiveness and safety of bariatric procedures for weight loss a pcornet cohort study. Ann Intern Med. 2018;169(11):741–750.
   PubMed Web of Science ®Google Scholar
• Lent MR, Hu Y, Benotti PN, et al. Demographic, clinical, and behavioral determinants of 7-year weight change trajectories in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis. 2018;14(11):1680–1685.
   PubMed Web of Science ®Google Scholar
• Wood GC, Benotti PN, Lee CJ, et al. Evaluation of the association between preoperative clinical factors and long-term weight loss after Roux-en-Y gastric bypass. JAMA Surg. 2016;151(11):1056–1062.
   PubMed Web of Science ®Google Scholar
• Higa K, Ho T, Tercero F, et al. Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up. Surg Obes Relat Dis. 2011;7(4):516–525.
   PubMed Web of Science ®Google Scholar
• Obeid NR, Malick W, Concors SJ, et al. Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data. Surg Obes Relat Dis. 2016;12(1):11–20.
   PubMed Web of Science ®Google Scholar
• Edholm D, Svensson F, Näslund I, et al. Long-term results 11 years after primary gastric bypass in 384 patients. Surg Obes Relat Dis. 2013;9(5):708–713.
   PubMed Web of Science ®Google Scholar
• Khorgami Z, Shoar S, Saber AA, et al. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus : a meta-analysis of randomized controlled trials. Obes Surg. 2018;29(3):964–974.
   Web of Science ®Google Scholar
• Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–2135.
   PubMed Web of Science ®Google Scholar
• Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695–704.
   PubMed Web of Science ®Google Scholar
• Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–256.e5.
   PubMed Web of Science ®Google Scholar
• Dixon JB, Chuang LM, Chong K, et al. Predicting the glycemic response to with type 2 diabetes. Diabetes Care. 2013;36(1):20–26.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zeng G, Tan J, et al. Impact of roux-en Y gastric bypass surgery on prognostic factors of type 2 diabetes mellitus: meta-analysis and systematic review. Diabetes Metab Res Rev. 2015;31(7):653–662.
   PubMed Web of Science ®Google Scholar
• Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013;23(1):93–102.
   PubMed Web of Science ®Google Scholar
• Panunzi S, Carlsson L, De Gaetano A, et al. Determinants of diabetes remission and glycemic control after bariatric surgery. Diabetes Care. 2016;39(1):166–174.
   PubMed Web of Science ®Google Scholar
• Panunzi S, De Gaetano A, Carnicelli A, et al. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis. Ann Surg. 2015;261(3):459–467.
   PubMed Web of Science ®Google Scholar
• Cohen R, Le Roux CW, Junqueira S, et al. Roux-En-Y gastric bypass in type 2 diabetes patients with mild obesity: a systematic review and meta-analysis. Obes Surg. 2017;27(10):2733–2739.
   PubMed Web of Science ®Google Scholar
• Cummings DE, Cohen RV. Bariatric/Metabolic surgery to treat type 2 diabetes in patients with a bmi <35 kg/m2. Diabetes Care. 2016;39(6):924–933.
   PubMed Web of Science ®Google Scholar
• Holman R. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589.
   PubMed Web of Science ®Google Scholar
• Billeter AT, Scheurlen KM, Probst P, et al. Meta-analysis of metabolic surgery versus medical treatment for microvascular complications in patients with type 2 diabetes mellitus. Br J Surg. 2018;105(3):168–181.
   PubMed Web of Science ®Google Scholar
• O’Brien R, Johnson E, Haneuse S, et al. Microvascular outcomes in patients with diabetes after bariatric surgery versus usual care. Ann Intern Med. 2018;169(5):300–310.
   PubMed Web of Science ®Google Scholar
• Madsen LR, Baggesen LM, Richelsen B, et al. Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes : a Danish population-based matched cohort study. Diabetologia. 2019;62(4):611–620.
   PubMed Web of Science ®Google Scholar
• Holst JJ, Madsbad S, Bojsen-Møller KN, et al. Mechanisms in bariatric surgery: gut hormones, diabetes resolution, and weight loss. Surg Obes Relat Dis. 2018;14(5):708–714.
   PubMed Web of Science ®Google Scholar
• Caiazzo R, Lassailly G, Leteurtre E, et al. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease. Ann Surg. 2014;260(5):893–899.
   PubMed Web of Science ®Google Scholar
• Raj PP, Gomes RM, Kumar S, et al. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians : “ NASHOST ” prospective observational trial. Surg Obes Relat Dis. 2015;11(6):1315–1322.
   PubMed Web of Science ®Google Scholar
• Ricci C, Gaeta M, Rausa E, et al. Long-term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia : a meta-analysis and meta-regression study with 5-year follow-up. Obes Surg. 2015;25(3):397–405.
   PubMed Web of Science ®Google Scholar
• Schiavon CA, Bersch-Ferreira AC, Santucci EV, et al. Effects of bariatric surgery in obese patients with hypertension the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension). Circulation. 2018;137(11):1132–1142.
   PubMed Web of Science ®Google Scholar
• Hallersund P, Sjöström L, Olbers T, et al. Gastric bypass surgery is followed by lowered blood pressure and increased diuresis - long term results from the Swedish Obese Subjects (SOS) study. PLoS One. 2012;7(11):1–10.
   Web of Science ®Google Scholar
• Courcoulas AP, Christian NJ, O’Rourke RW, et al. Preoperative factors and 3-year weight change in the Longitudinal Assessment of Bariatric Surgery (LABS) consortium. Surg Obes Relat Dis. 2015;11(5):1109–1118.
   PubMed Web of Science ®Google Scholar
• Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. Jama. 2012;308(11):1122–1131.
   PubMed Web of Science ®Google Scholar
• Kjær MM, Madsbad S, Hougaard DM, et al. The impact of gastric bypass surgery on sex hormones and menstrual cycles in premenopausal women. Gynecol Endocrinol. 2017;33(2):160–163.
   PubMed Web of Science ®Google Scholar
• Skubleny D, Switzer NJ, Gill RS, et al. The impact of bariatric surgery on polycystic ovary syndrome : a systematic review and meta-analysis. Obes Surg. 2016;26:169–176.
   PubMed Web of Science ®Google Scholar
• Kjær MM, Lauenborg J, Breum BM, et al. The risk of adverse pregnancy outcome after bariatric surgery: A nationwide register-based matched cohort study. Am J Obstet Gynecol. 2013;208(6):464.e1–464.e5.
   PubMed Web of Science ®Google Scholar
• Kjær MM, Nilas L. Pregnancy after bariatric surgery - A review of benefits and risks. Acta Obstet Gynecol Scand. 2013;92(3):264–271.
   PubMed Web of Science ®Google Scholar
• Sundbom M, Hedberg J, Marsk R, et al. Substantial decrease in comorbidity 5 years after gastric bypass: A population-based study from the Scandinavian obesity surgery registry. Ann Surg. 2017;265(6):1166–1171.
   PubMed Web of Science ®Google Scholar
• Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. J Am Med Assoc. 2012;307(1):56–65.
   PubMed Web of Science ®Google Scholar
• Eliasson B, Liakopoulos V, Franzén S, et al. Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: A nationwide, matched, observational cohort study. Lancet Diabetes Endocrinol. 2015;3(11):847–854.
   PubMed Web of Science ®Google Scholar
• Johnson BL, Blackhurst DW, Latham BB, et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216(4):545–556.
   PubMed Web of Science ®Google Scholar
• Fisher DP, Johnson E, Haneuse S, et al. Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity. J Am Med Assoc. 2018;320(15):1570–1582.
   Google Scholar
• Sundström J, Bruze G, Ottosson J, et al. Weight loss and heart failure: A nationwide study of gastric bypass surgery versus intensive lifestyle treatment. Circulation. 2017;135(17):1577–1585.
   PubMed Web of Science ®Google Scholar
• Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–761.
   PubMed Web of Science ®Google Scholar
• Arterburn DE, Olsen MK, Smith VA, et al. Association between bariatric surgery and long-Term survival. J Am Med Assoc. 2015;313(1):62–70.
   PubMed Web of Science ®Google Scholar
• Liakopoulos V, Franzén S, Svensson A, et al. Pros and cons of gastric bypass surgery in individuals with obesity and type 2 diabetes : nationwide, matched, observational cohort study. BMJ Open. 2019;9(1):9–12.
   Web of Science ®Google Scholar
• Gribsholt SB, Thomsen RW, Svensson E, et al. Overall and cause-specific mortality after Roux-en-Y gastric bypass surgery: A nationwide cohort study. Surg Obes Relat Dis. 2017;13(4):581–587.
   PubMed Web of Science ®Google Scholar
• Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health. 2009;9(88):1–20.
   PubMed Web of Science ®Google Scholar
• Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg. 2019;269(1):95–101.
   PubMed Web of Science ®Google Scholar
• Sjöström L, Gummesson A, Sjöström CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish obese subjects study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10(7):653–662.
   PubMed Web of Science ®Google Scholar
• Husain F, Jeong IH, Spight D, et al. Risk factors for early postoperative complications after bariatric surgery. Ann Surg Treat Res. 2018;95(2):100–110.
   PubMed Web of Science ®Google Scholar
• Wittgrove AC, Clark W, Tremblay T. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg. 1994;4(4):353–357.
   PubMed Web of Science ®Google Scholar
• The Longitudinal Assesment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, King WC, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009; 361(5):445–454.
   PubMed Web of Science ®Google Scholar
• Chang S, Stoll CRT, Song J, et al. The effectiveness and risks of bariatric surgery an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275–287.
   PubMed Web of Science ®Google Scholar
• Aminian A, Brethauer SA, Kirwan JP, et al. How safe is metabolic/diabetes surgery? Diabetes Obes Metab. 2015;17(2):198–201.
   PubMed Web of Science ®Google Scholar
• Gribsholt SB, Svensson E, Richelsen B, et al. Rate of acute hospital admissions before and after Roux-en-Y gastric bypass surgery. Ann Surg. 2018;267(2):319–325.
   PubMed Web of Science ®Google Scholar
• Telem DA, Talamini M, Gesten F, et al. Hospital admissions greater than 30 days following bariatric surgery : patient and procedure matter. Surg Endosc. 2015;29(6):1310–1315.
   PubMed Web of Science ®Google Scholar
• Smith MD, Patterson E, Wahed AS, et al. Relationship between surgeon volume and adverse outcomes after RYGB in Longitudinal Assessment of Bariatric Surgery (LABS) study. Surg Obes Relat Dis. 2010;6(2):118–125.
   PubMed Web of Science ®Google Scholar
• Stenberg E, Szabo E, Ågren G, et al. Early complications after laparoscopic gastric bypass surgery : results from the scandinavian obesity surgery registry. Ann Surg. 2014;260(6):1040–1047.
   PubMed Web of Science ®Google Scholar
• Stenberg E, Szabo E, Ågren G, et al. Closure of mesenteric defects in laparoscopic gastric bypass : a multicentre, randomised, parallel, open-label trial. Lancet. 2016;387(10026):1397–1404.
   PubMed Web of Science ®Google Scholar
• Gribsholt SB, Pedersen AM, Svensson E, et al. Prevalence of self-reported symptoms after gastric bypass surgery for obesity. JAMA Surg. 2016;151(6):504–511.
   PubMed Web of Science ®Google Scholar
• Nielsen JB, Pedersen AM, Gribsholt SB, et al. Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2016;12(8):1562–1568.
   PubMed Web of Science ®Google Scholar
• Salehi M, Vella A, Mclaughlin T, et al. Hypoglycemia after gastric bypass surgery: current concepts and controversies. J Clin Endocrinol Metab. 2018;103(8):2815–2826.
   PubMed Web of Science ®Google Scholar
• Marsk R, Jonas E, Rasmussen F, et al. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia. 2010;53(11):2307–2311.
   PubMed Web of Science ®Google Scholar
• Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2013;369(4):362–372.
   PubMed Web of Science ®Google Scholar
• Abrahamsson N, Börjesson JL, Sundbom M, et al. Gastric bypass reduces symptoms and hormonal responses in hypoglycemia. Diabetes. 2016;65(9):2667–2675.
   PubMed Web of Science ®Google Scholar
• Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient–2013 update: cosponsored by American association of clinical endocrinologists, the obesity society, and American society f. Endocr Pract. 2013;19(2):338–373.
   Web of Science ®Google Scholar
• Patel JJ, Mundi MS, Hurt RT, et al. Micronutrient deficiencies after bariatric surgery: an emphasis on vitamins and trace minerals. Nutr Clin Pract. 2017;32(4):471–480.
   PubMed Web of Science ®Google Scholar
• Weng T, Chang C, Dong Y, et al. Anaemia and related nutrient defi ciencies after Roux-en-Y gastric bypass surgery : a systematic review and meta-analysis. BMJ Open. 2015;5(7):1–11.
   Web of Science ®Google Scholar
• McCracken E, Wood GC, Prichard W, et al. Severe anemia after Roux-en-Y gastric bypass: a cause for concern. Surg Obes Relat Dis. 2018;14(7):902–909.
   PubMed Web of Science ®Google Scholar
• Karefylakis C, Näslund I, Edholm D, et al. Prevalence of anemia and related deficiencies 10 years after gastric bypass — a retrospective study. Obes Surg. 2015;25(6):1019–1023.
   PubMed Web of Science ®Google Scholar
• Obinwanne KM, Fredrickson KA, Farnen JP, et al. Incidence, treatment, and outcomes of iron deficiency after laparoscopic Roux-en-Y gastric bypass : a 10-year analysis. J Am Coll Surg. 2014;218(2):246–252.
   PubMed Web of Science ®Google Scholar
• Salgado W, Modotti C, Nonino CB, et al. Anemia and iron deficiency before and after bariatric surgery. Surg Obes Relat Dis. 2014;10(1):49–54.
   PubMed Web of Science ®Google Scholar
• Schauer PR, Mingrone G, Ikramuddin S, et al. Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes. Diabetes Care. 2016;39(6):902–911.
   PubMed Web of Science ®Google Scholar
• Worm D, Madsbad S, Kristiansen VB, et al. Changes in hematology and calcium metabolism after gastric bypass surgery — a 2-year follow-up study. Obes Surg. 2015;25(9):1647–1652.
   PubMed Web of Science ®Google Scholar
• Yu EW. Bone metabolism after bariatric surgery. J Bone Miner Res. 2014;29(7):1507–1518.
   PubMed Web of Science ®Google Scholar
• Crawford MR, Pham N, Khan L, et al. Increased bone turnover in type 2 diabetes patients randomized to bariatric surgery versus medical therapy at 5 years. Endocr Pract. 2017;24(3):256–264.
   PubMed Web of Science ®Google Scholar
• Yu EW, Bouxsein ML, Putman MS, et al. Two-year changes in bone density after Roux-en-Y. J Clin Endocrinol Metab. 2015;100(4):1452–1459.
   PubMed Web of Science ®Google Scholar
• Madsen LR, Espersen R, Ornstrup MJ, et al. Bone health in patients with type 2 diabetes treated by Roux-en-Y gastric bypass and the role of diabetes remission. Obes Surg. 2019. DOI:10.1007/s11695-019-03753-3,
   Web of Science ®Google Scholar
• Shanbhogue VV, Støving RK, Frederiksen KH, et al. Bone structural changes after gastric bypass surgery evaluated by HR-pQCT: a two-year longitudinal study. Eur J Endocrinol. 2017;176(6):685–693.
   PubMed Web of Science ®Google Scholar
• Axelsson KF, Werling M, Eliasson B, et al. Fracture risk after gastric bypass surgery : a retrospective cohort study. J Bone Miner Res. 2018;33(12):2122–2131.
   PubMed Web of Science ®Google Scholar
• Yu EW, Lee MP, Landon JE, et al. Fracture risk after bariatric surgery : Roux-en-Y gastric bypass versus adjustable gastric banding. J Bone Miner Res. 2017;32(6):1229–1236.
   PubMed Web of Science ®Google Scholar
• Lu C-W, Chang Y-K, Chang -H-H, et al. Fracture risk after bariatric surgery: A 12-year nationwide cohort study. Med. 2015;94(48):1–7.
   Web of Science ®Google Scholar
• Nakamura KM, Haglind EGC, Clowes JA, et al. Fracture risk following bariatric surgery : a population-based study. Osteoporos Int. 2014;25(1):151–158.
   PubMed Web of Science ®Google Scholar
• Rousseau C, Jean S, Gamache P, et al. Change in fracture risk and fracture pattern after bariatric surgery : nested case-control study. Bmj. 2016;354(i3794):1–12.
   Google Scholar
• Lalmohamed A, Vries F D, Bazelier MT, et al. Risk of fracture after bariatric surgery in the United Kingdom : population based, retrospective cohort study. Bmj. 2012;345(e5085):1–12.
   Google Scholar
• Backman O, Stockeld D, Rasmussen F, et al. Alcohol and substance abuse, depression and suicide attempts after Roux-en-Y gastric bypass surgery. Br J Surg. 2016;103(10):1336–1342.
   PubMed Web of Science ®Google Scholar
• King WC, Chen J, Courcoulas AP, et al. Alcohol and other substance use after bariatric surgery : prospective evidence from a U.S. multicenter cohort study. Surg Obes Relat Dis. 2017;13(8):1392–1402.
   PubMed Web of Science ®Google Scholar
• Castaneda D, Popov VB, Wander P, et al. Risk of suicide and self-harm is increased after bariatric surgery — a systematic review and meta-analysis. Obes Surg. 2019;29(1):322–333.
   PubMed Web of Science ®Google Scholar
• Genser L, Rossario J, Mariolo C, et al. Obesity, type 2 D iabetes, and the metabolic syndrome pathophysiologic relationships and guidelines for surgical intervention. Surg Clin NA. 2019;96(4):681–701.
   Web of Science ®Google Scholar
• Davies MJ, Alessio DAD, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41( December):2669–2701.
   Google Scholar
• Maciejewski ML, Winegar DA, Farley JF, et al. Risk stratification of serious adverse events after gastric bypass in the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2012;8(6):671–677.
   PubMed Web of Science ®Google Scholar
• Demaria EJ, Murr M, Byrne TK, et al. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg. 2007;246(4):578–584.
   PubMed Web of Science ®Google Scholar
• Still CD, Wood GC, Benotti P, et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery : a retrospective cohort study. Lancet Diabetes Endocrinol. 2014;2(1):38–45.
   PubMed Web of Science ®Google Scholar
• Aminian A, Brethauer SA, Andalib A, et al. Individualized metabolic surgery score: procedure selection based on diabetes severity ali. Ann Surg. 2014;266(4):650–657.
   Web of Science ®Google Scholar
• Kenngott HG, Clemens G, Gondan M, et al. DiaSurg 2 trial - surgical vs. medical treatment of insulin-dependent type 2 diabetes mellitus in patients with a body mass index between 26 and 35 kg/m2: study protocol of a randomized controlled multicenter trial - DRKS00004550. Trials. 2013;14(1):183.
   PubMed Web of Science ®Google Scholar
• O’Neil PM, Birkenfeld AL, Mcgowan B, et al. Articles Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity : a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 2018;392(10148):637–649.
   PubMed Web of Science ®Google Scholar
• Maiorino MI, Chiodini P, Bellastella G, et al. Insulin and glucagon-like peptide 1 receptor agonist combination therapy in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2017;40(4):614–624.
   PubMed Web of Science ®Google Scholar
• Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost- effectiveness of bariatric (weight loss) surgery for obesity : a systematic review and economic evaluation. Health Technol. Assess. 2009;13(41). DOI:10.3310/hta13410.
   Google Scholar
• Keating C, Neovius M, Sjöholm K, et al. Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status : results from the Swedish obese subjects study. Lancet Diabetes Endocrinol. 2015;3:855–865.
   Google Scholar
• Wcitd.com[Internet]. The 4ʹth world congress on interventional therapies for type 2 diabetes. [Accessed 2019 Apr 11]. Available from: https://wcitd.com/
   Google Scholar